期刊文献+

氯氮平和经典抗精神病药的长期治疗对患者体重、糖代谢及血脂的影响 被引量:14

The effects of long duration treatment of clozapine and typical antipsychotics on patients' body weight,metabolism of glucose and lipids
下载PDF
导出
摘要 目的探讨长期应用氯氮平和经典类抗精神病药(APS)对精神分裂症患者体重、血糖和血脂等代谢指标的影响及其可能的相关因素。方法共调查使用APS≥5年的精神分裂症患者271例,分别测量其身高和体重,检测空腹和餐后2h血糖、空腹血清游离脂肪酸、血清胰岛素和瘦素水平。按药物使用情况将患者分为氯氮平组、经典APS单一治疗组(经典组)或联合用药组进行比较。结果①联合用药组体质量指数、空腹血糖、血甘油三酯和血游离脂肪酸水平均显著高于经典组(P<0·05);血胰岛素和胰岛素抵抗指数也均显著高于经典组和氯氮平组(P<0·05)。②氯氮平组和联合用药组糖耐量降低和2型糖尿病发生率均明显高于经典组(P<0·05)。③患者体质量指数与其空腹血糖、血清瘦素、血甘油三酯、胆固醇水平以及与胰岛素抵抗指数均呈正相关(P均小于0·05);患者血清瘦素水平与其血胰岛素水平也呈正相关(P=0·008)。④多元逐步线型回归分析表明,进入影响空腹血糖水平方程的因素分别为胰岛素抵抗指数、血胰岛素、胆固醇和体质量指数(P<0·05)。结论单用氯氮平及其与经典抗精神病药联用,均易导致患者肥胖,且易导致患者血糖、血脂、血游离脂肪酸水平升高,并与胰岛素抵抗和糖耐量降低发生相关,可能增加2型糖尿病的发生。 Objective To explore how the long duration treatment of clozapine and typical antipsychotics (APS) impacted on body weight, fasting blood glucose and serum lipids in schizophrenic patients. Methods 271 cases of schizophrenic patients with more than 5 year treatment were investigated. The height and body weight, fasting and 2-hour after meal blood glucose, fasting serum free fatty acids( FFA), serum insulin and leptin level of all patients were measured re- spectively. All patients were divided into three groups: single-use clozapine group (SCG), single-use typical APS group (SAPSG) and co-use of colzapine and typical APS group (CUG). Results ①The body weight, fasting blood glucose, blood glyceride, and serum FFA levels in the patients of CUG were markedly higher than those in patients of SAPSG ( All P 〈0.05 ). Serum insulin levels and Homeostasis model of assessment of insulin resistance (HOMA-IR) in patients of CUG were also remarkably higher than those in patients of SAPSG and SCG ( P 〈 O.05 ). ②The incidence rates of impaired glucose tolerance (IGT) and type 2 diabetes mellitus in patients of SCG and CUG were significantly higher than those in patients of SAPSG ( P 〈 0.05 ). ③The body mass index of patients were positively correlated with fasting blood glucose, serum leptin levels, blood glyceride, cholesterol, and HOMA-IR, respectively ( r = 0.154, 0.557,0. 436, 0.199, and 0.144, respectively;P 〈0.05). Serum leptin levels were also positively correlated with insulin (r =0.194, P =0.008).④Multiple stepwise linear regression analysis indicated that all variables enterin~ into the fourth multivariate model at the0.05 significance level were HOMA-IR, serum insulin, serum cholesterol, and body mass index; ( R^2 = 0.829). Conclusions Long duration of clozapine either alone or in combination with typical antipsychoties both easily induced elevations of body weight, fasting blood glucose, serum lipids, and serum FFA. These elevations might relate to insulin resistance and IGT, and increase the incidence of type 2 diabetes mellitus.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2008年第2期65-68,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 抗精神病药 体重 糖代谢 血脂 Antipsychotics Body weight Metabolism of glucose Serum lipids
  • 相关文献

参考文献13

  • 1Lieberman JA, Tollefson G, Tohen M, et al. Comparative efficacy and saftey of atipical and conventional antipsychotic drugs in first- episode psychosis : A randomized, double-blind trial of olanzapine versus haloperidol[J].Am J Psychiatry, 2003,160(8) : 1401 - 1403.
  • 2王从杰,孙静,张志珺.抗精神病药与2型糖尿病[J].临床精神医学杂志,2004,14(5):313-314. 被引量:18
  • 3Casey DE, Zorn SH. The pharmacology of weight gain with antispychotics[J].J Clin Psychiatry ,2001,62 ( suppl7 ) :4 - 10.
  • 4Newcomer JW. Metabolic disturbances assciated with antipsychotic use[J]. J Clin Psychiatry, 2001,62(supp127):3 -4.
  • 5Buse JB, Cavazzoni P, Hombuckle K, et al. A retrospective cohort study of diabetes mellitus and antipsychofic treatment in the United States[ J ]. J Clin Epidemiol,2003,56 (2) : 164 - 170.
  • 6Henderson DC. Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence? [J] CNS Drugs, 2002, 16:77 -89.
  • 7Hawkins M, Tonelli J, Kishore P. Contribution of elevated free acid levels to the lack of glucose effectives in type 2 diabetes[ J]. Diabetes, 2003, 52( 11 ) :2748 -2758.
  • 8Kolaczynski JW, Nyce MR, Considine RN, et al. Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro[J]. Diabetes,1996, 45(5) :699 -705.
  • 9Zhang ZJ, Yao ZJ, Liu W, et al. Effects of antipsychotics on fat deposition and changes in leptin and insulin levels[ J]. Br J Psychiatry, 2004,184( 1 ) :58 -62.
  • 10Hagg S, Joelsson L, Mjondal T, et al. Prevalence of diabetes and impaired glueosetoleranee in patients with conventional depot neu- roleptie medications[J]. J Clin Psychiatry, 1998,59 ( 6 ) : 294 - 299.

二级参考文献15

  • 1Casey DE,Zorn SH.The pharmacology of weight gain with antipsychotics[J].J Clin Psychiatry,2001,62(Suppl 7):5-7.
  • 2Lieberman JA,Tollefson G,Tohen M,et al.Comparative efficacy and saftey of atipical and conventional antipsychotic drugs in first-episode psychosis:A randomized,double-blind trial of olanzapine versus haloperidol[J].Am J Psychiatry,2003,160:1401-1403.
  • 3Zhang ZJ,Yao ZJ,Liu W.Effects of antipsychotics on fat deposition and changes in leptin and insulin levels[J].Br J Psychiatry,2004,184:58.
  • 4Buse JB.Metabolic side effects of astipsychtics:focus on hyperglycemia and diabetes[J].J Clin Psychiatry,2002,63(Suppl 4):37-41.
  • 5Sernyak MJ,Leslie DL,Alarcon RD,et al.Association of diabetes mellitus with use of atypical neuroleptic in the treatment of schizophrenia[J].Am J Psychiatry,2002,159:561-566.
  • 6Hgg S,joelsson L,Mjndal T,et al.Prevalence of diabetes and impaired glucose tolerance in patients with conventional depot neuroleptic medications[J].J Clin Psychiatry,1998,59:294-295.
  • 7Mir S,Taylor D.Atypical antipsychotics and hyperglycaemia[J].Int Clin Psychopharmacol,2001,16:63-73.
  • 8Jin H,Meyer JM,Jeste DV.Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associaated with atypical antipsychotic:an analysis of 45 published cases[J].Ann Clin Pschiatry,2002,14:59-64.
  • 9Henderson DC,Cagliero E, Gray C,et al.Clozapine, diabetes mellitus,weight gain,and lipid abnormalities:a five-year naturalistic study[J].Am J Psychiatry,2000,157:978.
  • 10Ananth J,Venkatesh R,Burgoyne K,et al.Atypical antipsychotic drug use and diabetes[J].Pschother Psychosom,2002,71:244-254.

共引文献17

同被引文献137

引证文献14

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部